SERPINB5 and lung adenocarcinoma: In line with our findings, a bioinformatics study by He et al. showed that Serpinb5 expression was upregulated in lung adenocarcinoma and hypomethylated, with associations with poor survival in patients with higher Serpinb5 expression suggesting its role as a possible therapeutic target [39].